What are BioMarin Pharmaceuticals's profit margins?

BioMarin Pharmaceuticals (BMRN) runs a 76.5% gross margin and a 19.9% operating margin, with a 16.8% net margin.

Where do BioMarin Pharmaceuticals's ratios come from?

Every ratio is computed from BioMarin Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

BioMarin Pharmaceuticals BMRN Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	76.5%-2.9pp	77.7%-1.9pp	81.3%+2.5pp	79.6%-0.3pp	79.4%+0.5pp
EBITDA margin	13.5%-10.6pp	16.7%-3.7pp	22.6%+6.2pp	28%+13.6pp	24.1%+11.3pp
Free cash flow margin	23.7%+2.5pp	22.5%+5.4pp	26.9%—	22.7%—	21.2%—
Returns
Return on invested capital	5.2%-3.3pp	6.6%-1.4pp	8.8%+3.6pp	10.7%+6.6pp	8.5%+5.3pp
Efficiency
Asset turnover	0.4×0.0×	0.4×0.0×	0.4×0.0×	0.4×0.0×	0.4×0.0×
Inventory turnover	0.6×+0.1×	0.6×+0.1×	0.5×-0.1×	0.5×0.0×	0.5×0.0×
Liquidity
Current ratio	5.8×+0.3×	5.2×-0.1×	4.8×+0.6×	5.6×+2.5×	5.5×+2.8×
Quick ratio	4.2×+0.7×	3.5×+0.2×	3.1×+0.5×	3.6×+1.7×	3.5×+1.8×
Cash ratio	3.9×+2.2×	1.7×+0.2×	1.6×+0.6×	1.8×+0.9×	1.7×+1.0×
Leverage
Debt-to-equity	0.2×+0.1×	0.1×+0.1×	0.1×0.0×	0.1×-0.2×	0.1×-0.2×
Debt-to-assets	0.2×+0.1×	0.1×+0.1×	0.1×0.0×	0.1×-0.1×	0.1×-0.1×
Net debt / EBITDA	-3.8×-3.1×	-1.2×+0.3×	-0.9×-0.8×	-0.7×-2.4×	-0.6×-3.3×
Interest coverage	15.8×-35.9×	41.9×+3.7×	57.5×+35.9×	70×+54.3×	51.7×+39.4×
Per Share
Book value per share	$31.43+6.6%	$30.84+7.2%	$31.54+14.9%	$30.58+16.0%	$29.49+15.8%
Valuation
Market capitalization	$10.86B-19.4%	$11.42B-8.9%	$10.4B-22.3%	$10.49B-32.9%	$13.49B-18.2%
Enterprise value	$9.22B-29.3%	$10.75B-7.5%	$9.75B-26.7%	$9.87B-39.3%	$13.04B-24.8%
Price / sales	3.4×-1.2×	3.5×-0.8×	3.4×-1.5×	3.4×-2.6×	4.6×-2.1×
Price / book	1.7×-0.6×	1.9×-0.3×	1.7×-0.8×	1.7×-1.2×	2.3×-0.9×
EV / EBITDA	21.1×+2.8×	20×0.0×	14×-15.6×	11.5×-32.1×	18.3×-36.3×
EV / sales	2.8×-1.6×	3.3×-0.7×	3.2×-1.7×	3.2×-3.1×	4.4×-2.6×
Free cash flow yield	7.1%+2.4pp	6.3%+2.5pp	8%—	6.6%—	4.6%—

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about BioMarin Pharmaceuticals.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are BioMarin Pharmaceuticals's profit margins?: BioMarin Pharmaceuticals (BMRN) runs a 76.5% gross margin and a 19.9% operating margin, with a 16.8% net margin.
Where do BioMarin Pharmaceuticals's ratios come from?: Every ratio is computed from BioMarin Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.